Brief: EDAP Announces Reimbursement Approval In Switzerland For Use Of High-Intensity Focused Ultrasound In Treatment Of Prostate Cancer
26/07/2023 13:07
July 26 (Reuters) - Edap Tms SA EDAP.O :
* EDAP ANNOUNCES REIMBURSEMENT APPROVAL IN SWITZERLAND FOR
THE USE
OF HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) IN THE TREATMENT OF
PROSTATE CANCER
* EDAP TMS SA - REIMBURSEMENT TOOK EFFECT ON JULY 1, 2023
Source text for Eikon: ID:nGNXx00zr
Further company coverage: EDAP.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Edap Tms SA
See all newsEdap Tms SA reports results for the quarter ended June 30 - Earnings Summary
FocalTherics slides after $40 million share sale
Brief: Focaltherics™ Announces Pricing Of Public Offering Of American Depositary Shares
Brief: Focaltherics™ Announces Proposed Public Offering Of American Depositary Shares
Edap Tms SA expected to post a loss of 20 cents a share - Earnings Preview